COVID-19 VACCINE NOW AVAILABLE! PLEASE CALL THE PHARMACY TO BOOK YOUR APPOINTMENT!

Get Healthy!

Results for search "Viruses".

23 Jun

Is US Reopening Too Quickly ?

There are still confirm cases of COVID-19.

22 Jun

COVID-19 May Trigger Diabetes In Previously Healthy People, New Study Finds.

Experts believe the virus may be attacking organs involved with sugar metabolism.

Health News Results - 1076

Birthday celebrations raised the risk of spreading SARS-CoV-2 by 30% last year in U.S. counties with high rates of COVID-19, according to a new study.

No such surge was seen in places with low rates of infection.

For the study, researchers at Harvard Medical School and the RAND Corporation analyzed health insurance claims data from nearly 3 million U.S. households in the first 45 we...

After spending billions to speed the creation of COVID-19 vaccines, the United States said Thursday that it will now devote $3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage.

Along with "accelerating things that are already in progress" for COVID-19, the new program would also encourage treatments for other viruses, Dr. ...

Aiming to deliver a one-two punch to the herpes virus, animal research on an experimental drug found it tackled active infections and reduced or eliminated the risk of future outbreaks.

Existing treatments, such as Zovirax, Valtrex or Famvir, are only effective at the first task; they can help treat cold sores and genital eruptions once a herpes outbreak occurs. But...

People living with HIV have to take powerful drug cocktails to keep their disease in check, but a new study finds they also need to worry about a doubled risk of sudden cardiac death.

Unlike a heart attack caused by a blocked heart artery, sudden cardiac death can happen without warning and is triggered by an electrical malfunction that causes an irregular heartbeat. Within minutes, there...

People who have had severe COVID-19 and worry about going through another bout of it can relax: New research finds that less than 1% of people who've had a severe coronavirus infection get re-infected.

For the study, University of Missouri researchers analyzed data from more than 9,100 COVID-19 patients at 62 health facilities in the United States.

Only 0.7% of patients with sever...

Public health precautions meant to reduce the spread of COVID-19 may have had an unintended but happy side effect.

They may also have benefited individuals who have chronic obstructive pulmonary disease (COPD), according to a new study.

During the pandemic, admissions for COPD flare-ups dropped dramatically -- by 53% -- at University of Maryland Medical System (UMMS) hospitals.

<...

British researchers report that babies have a strong immune response to the virus that causes COVID-19, based on a new, small study.

For the research, the investigators assessed the immune systems of four infants under 3 months of age who had recovered from COVID, and compared them with adults who also had recovered from the disease.

Compared to adults, the babies produced relative...

As the number of people fully immunized against COVID-19 rises into the hundreds of millions, immunologists and infectious disease experts now are pondering a new question in the unfolding pandemic.

Namely, how long will vaccine immunity last, and will people who've gotten the jab need booster shots to maintain their protection?

It's an important question, as waning immunity in the ...

After Texas relaxed COVID-19 restrictions, other respiratory illnesses -- such as colds, bronchitis and pneumonia -- made rapid rebounds.

Pathologists from Houston Methodist Hospital found that the rhinovirus and enterovirus infections that can trigger these illnesses started rebounding in the fall of last year after Texas eased capacity limits in bars and restaurants.

More recently...

A real-world study shows that even when folks who get the Pfizer and Moderna COVID-19 vaccines do have 'breakthrough' infections, those illnesses are mild.

The study, from researchers at the U.S. Centers for Disease Control and Prevention, is among the first to show that people who get COVID-19 despite being fully or partially vaccinated are less likely to have serious illness or to infec...

It has been an elusive goal so far -- finding a potent treatment that can beat back the new coronavirus before it grabs a hold of a patient's immune system and sends it into overdrive.

But new research suggests that more than a dozen existing drugs or drugs under development may do the trick.

Investigators tested more than 12,000 drugs in two different types of human cells infected ...

In some good news for those who have already suffered through a bout of COVID-19, a new study finds they may have a much lower risk of reinfection for at least 10 months.

For the study, the researchers analyzed rates of SARS-CoV-2 infections between October 2020 and February 2021 among more than 2,000 nursing home residents (median age 86) and staff. Antibody testing was used to determine...

Moderna plus Pfizer? J&J plus Moderna? There's a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19.

"Although the vaccines currently authorized by the U.S. Food and Drug Administration offer strong protection against COVID-19, we need to prepare for the possibility of ne...

COVID-19 does not pose a threat to the safety of the United States' blood supply under existing donor screening guidelines, researchers report.

For the study, the investigators reviewed the results of tests for the presence of SARS-CoV-2 in nearly 18,000 pools of donated blood, representative of over 257,800 single blood donations that were collected between March and September 2020 from ...

Low testosterone levels may increase men's risk of severe COVID-19, according to a new study.

On average, men fare worse with COVID-19 than women.

"During the pandemic, there has been a prevailing notion that testosterone is bad. But we found the opposite in men," said senior study author Dr. Abhinav Diwan. He's professor of medicine, cell biology and physiology at Washington Univer...

If you can't stand broccoli, celery or kale, you may be a supertaster, and it just might protect you from COVID-19.

Supertasters are folks who are highly sensitive to bitterness. They're not only less likely to get COVID-19 than people who aren't so sensitive to sharp, pungent flavors, they're also less likely to wind up hospitalized with it, the researchers said.

What's more, super...

The virus fueling the COVID-19 pandemic could become just an ordinary sniffle-causing nuisance within the next 10 years, a new study suggests.

Researchers stressed that the projection is based on mathematical models, and not a crystal-ball prediction.

But, they say, given what's known about the human immune response to SARS-CoV-2 -- the virus that causes COVID-19 -- it is possible t...

MONDAY, May 24, 2021 (HealthDay News) - As researchers work to learn more about COVID-19 and so-called long-haulers, a new study suggests "brain fog" can persist and even worsen for those who were infected months before.

Long-haulers continue to have symptoms long after their COVID diagnosis, and these symptoms can be mental as well as physical.

"People have trouble problem-solving,...

A new coronavirus that appears to have jumped from a dog to a child has been discovered from a case three years ago, but it's unclear what threat it may pose.

This new canine-like coronavirus was found in a child in Malaysia in 2018. If it is confirmed as a human pathogen, it could be the eighth coronavirus known to cause disease in people.

The case suggests that transmission of cor...

Researchers have reported the first case of COVID-19 causing dangerous, recurring blood clots in a patient's arm.

The report offers new insight into how the damage of inflammation caused by COVID-19 can linger and how best to treat recurring clots, the Rutgers University researchers said.

There have been reports of lower extremity blood clots in patients after COVID-19, but this is ...

New insight into a rare and dangerous disorder that can occur in kids with COVID-19 could improve treatment of the condition, researchers say.

Many children infected with SARS-CoV-2 (the virus that causes COVID-19) go undiagnosed or have no symptoms, but about one in 1,000 develop a condition called multisystem inflammatory syndrome in children (MIS-C) within four to six weeks.

Symp...

Men now have one more compelling reason to get a COVID-19 vaccine - doctors suspect the new coronavirus could make it hard to perform in the bedroom.

How? Coronavirus infection is already known to damage blood vessels, and vessels that supply blood to the penis appear to be no exception.

Researchers armed with an electron microscope found coronavirus particles in penile tissue ...

Like certain health conditions including cancer, diabetes and high blood pressure, new research shows that having HIV or AIDS increases a person's risk of catching and dying from COVID-19.

For the study, researchers from Penn State College of Medicine assessed data from 22 previous studies of 21 million participants in North America, Africa, Europe and Asia.

The investigators ...

Neurological problems are occurring in a very high percentage of hospitalized COVID-19 patients -- and what's worse, those symptoms foretell a bad end for many sufferers, a new study finds.

About four out of five people sick enough to be hospitalized for COVID-19 suffer some sort of neurological problem, ranging from headache and a loss of sense of smell to confusion, delirium, stroke a...

Heart complications are rare among college athletes who have had COVID-19, according to a small study.

"Our findings may offer reassurance to high school athletes, coaches and parents where resources for testing can be limited," said senior author Dr. Ranjit Philip, assistant professor in pediatric cardiology at the University of Tennessee Health Science Center, in Memphis.

For the ...

It's long been known that obesity is a risk factor for severe COVID-19 in infected people. But new research suggests that the connection may be even stronger for men than women.

Researchers at Montefiore Medical Center in New York City analyzed data from more than 3,500 COVID-19 patients admitted to the hospital between early March and May 1, 2020.

Both moderate (a body mass index ...

Two doses of the Pfizer-BioNTech COVID-19 vaccine provide a high level of protection for populations, a new study shows.

The findings from Israel -- the first nation to report national data on the vaccine -- show that two doses provide more than 95% protection for people 16 and older against COVID-19 infection, hospitalization and death.

The study period was from Jan. 24 to April 3,...

Two widely used COVID-19 vaccines -- Pfizer and Moderna -- will likely remain powerfully protective against developing serious illness even if coronavirus variants somehow manage to infect vaccinated patients, new research suggests.

Both vaccines are based on messenger RNA (mRNA) technology. And investigators say that, at least in theory, such technology can deploy multiple levels of defe...

Cancer might seem like a modern problem, but new research has revealed that it affected up to 14% of adults in medieval Britain.

University of Cambridge researchers used X-rays and CT scans to search for evidence of cancer inside skeletal remains excavated as part of an ongoing study of medieval life.

The investigators found rates of cancer about 10 times higher than had been previ...

While COVID-19 research efforts must now shift toward the development of a pill that can prevent serious illness in the recently infected, experts say.

"We need a pill that can keep people out of the hospital, and the time to develop that is right now," Dr. Rajesh Gandhi said during a Thursday media briefing by the Infectious Diseases Society of America. He is director of HIV Clinical Ser...

COVID-19 infections may last longer in young people with weakened immune systems, and that extended period could lead to more mutations in SARS-CoV-2, according to the authors of a new case study.

The study included two children and a young adult who had weakened immune systems due to treatment for acute lymphoblastic leukemia. For months, they tested positive for SARS-CoV-2, the virus th...

Just 2% of young dental patients without COVID-19 symptoms tested positive for the new coronavirus, according to a new study.

Kids with COVID-19 are typically asymptomatic but can carry high levels of SARS-CoV-2 and spread it to others, University of Illinois Chicago (UIC) researchers noted.

Their study included 921 patients, aged 2 to 18, who had emergency dental procedures at UIC ...

The risk of mother-to-newborn transmission of COVID-19 is low, but the illness in pregnant women can trigger preterm birth, researchers say.

The new study looked at 255 babies born in Massachusetts last year to mothers with a recent positive test for COVID-19.

Only about 2% of the 88% of babies who were tested for COVID-19 had a positive result.

But worsening COVID-19 illness ...

Not even your beloved feline is safe from COVID-19.

Using in-depth genetic analyses, a new investigation in the United Kingdom suggests that people can pass COVID-19 on to their cats.

"We identified two cats that tested positive," said study lead author Margaret Hosie. "Both of them were from suspected COVID-19 households."

One case involved a 6-year-old female Siame...

Isolated NBA players who recovered from COVID-19 but still tested positive for the virus didn't infect others after leaving isolation, a new study finds.

That someone who has had COVID can infect others has been a persistent fear, but these findings from the professional basketball league suggest that many who recover can return to contact with others without spreading the virus, research...

For people who've suffered through a bout of COVID-19, their misery is too often not over. New research shows that a wide variety of "long-haul" symptoms are common, and the risk rises along with the severity of their case of COVID-19.

In what may be the largest such study to date, "the findings show that beyond the first 30 days of illness, substantial burden of health loss -- spanning ...

COVID-19 "breakthrough" infections, where someone who's been fully vaccinated becomes infected nonetheless, are exceedingly rare, a new study suggests.

Researchers at Rockefeller University in New York City said they uncovered just two breakthrough infections in a group of 417 university employees who were all more than two weeks out from their second dose of either the Pfizer-BioNTech or...

If you're in a public restroom, you may not want to hang around too long, because lots of airborne pathogens are hanging around, too.

Researchers from Florida Atlantic University's College of Engineering and Computer Science conducted flush tests in a public restroom with both a toilet and a urinal.

"After about three hours of tests involving more than 100 flushes, we found a substa...

Eviction bans during the COVID-19 pandemic reduced infection rates not only in people who avoided displacement but also in their communities, according to a new study.

"When it comes to a transmissible disease like COVID-19, no neighborhood is entirely isolated," said study author Alison Hill, assistant professor of biomedical engineering at Johns Hopkins University, in Baltimore.

I...

Four in 10 transgender women have HIV, which shows the urgent need to offer them more prevention and treatment services, according to a new U.S. Centers for Disease Control and Prevention report.

In interviews with more than 1,600 transgender women in Atlanta, Los Angeles, New Orleans, New York City, Philadelphia, San Francisco and Seattle in 2019 and early 2020, researchers found that 42...

In very rare cases, children infected with the new coronavirus can develop a severe illness known as multisystem inflammatory syndrome (MIS-C). Now, research finds that these young patients often develop neurologic symptoms along with the respiratory issues they might face.

These neurologic symptoms were present in half of children who were hospitalized with MIS-C, U.K. researchers say.

Two new studies out of Britain find that although the now-dominant "U.K. variant" of the new coronavirus does spread more quickly, it does not appear to lead to more severe disease in those made ill.

The findings should help allay fears that more patients will die after infection with the variant, officially labeled B.1.1.7.

Scientists published the findings online April 12 in two

COVID-19 might have a tough new foe: The sun.

New research shows that sunnier regions of the United States have lower COVID-19 death rates than cloudier areas, suggesting that the sun's UV rays might somehow provide some protection against the disease.

The effect is not due to better uptake of the healthy "sunshine vitamin," vitamin D, noted the Scottish research team led by Richard...

Two COVID-19 vaccines appear to work well against a rapidly spreading coronavirus variant that arose in California, but less effective against a variant that first emerged in South Africa, researchers report.

"The good news is the California variant does not appear to be a problem for our current vaccines," said study author David Montefiori, director of the Laboratory for AIDS Vaccine Re...

Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it's highly doubtful the vaccine is to blame, according to a just-published case study.

Although both people were in the same trial, one was given the vaccine and the other was given a placebo of saline solution.

"That strengthens the possibility that the case in our report may have be...

COVID-19 is so contagious that even a single breach of social distancing measures can have far-reaching consequences.

A case in point: An explosion of new COVID-19 cases traced to five people who joined in on a bar's opening night in rural Illinois in February.

Four of the five who attended the crowded gathering (the bar's capacity was 100 people) were already experiencing symptom...

There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months.

The new study tracked 33 participants in the trials that led to the vaccine's approval. Six months after having received their second vaccine dose, "antibody activity remained high in al...

Because of the COVID-19 pandemic, scientists thought twice about studying North American bats in their winter habitats. But they've now determined that the risk of humans passing the coronavirus to bats under these conditions was low.

The U.S. Geological Survey (USGS) led the study. It found the risk to be one in 1,000 with no protective measures and one in 3,333 with proper use of per...

Kids will be kids, and that's exactly why Holly McDade plans to get her three young children the COVID-19 vaccine as soon as it becomes available to them.

"Little kids can't help but touch their mouths and their noses and touch other things," said McDade, 32, of Strasburg, Va. "They just don't think about it. It's not where their brains are at yet."

McDade isn't concerned so much ab...

It's the question everyone wants answered because reopening the world depends on it: Can coronavirus vaccines stop transmission of the virus?

Now, 21 universities across the United States are teaming up to find out.

The project, called Prevent COVID U, was started by the COVID-19 Prevention Network housed at the Fred Hutchinson Cancer Research Center in Seattle.

The study inc...

Show All Health News Results